ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Army of Women, caBIG To Collaborate.

August 7, 2009

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

June 10, 1988

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984

RFPs Available

May 5, 2000

With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA

August 2, 2013